作者:Meguro, Masaki、Miyauchi, Satoru、Kanao-Arisumi, Yukiko、Naito, Satoru、Suzuki, Kanae、Inoue, Shinichi、Yamada, Keisuke、Homma, Tsuyoshi、Chiba, Kiyoshi、Nara, Futoshi、Furuzono, Shinji
DOI:10.1016/j.bmc.2024.117775
日期:——
4-[(5-[2-Methyl-5-(methylsulfonyl)pentan-2-yl]sulfonylpyrimidin-4-yl)amino]benzonitrile was identified as a novel potent aldosterone synthase inhibitor. Compound was found to inhibit human CYP11B2 in the nanomolar range, and showed an aldosterone-lowering effect in a furosemide-treated cynomolgus monkey model. Although human CYP11B2 has the high homology sequence with human CYP11B1, compound showed
4-[(5-[2-甲基-5-(甲基磺酰基)戊-2-基]磺酰基嘧啶-4-基)氨基]苯甲腈被鉴定为一种新型有效的醛固酮合酶抑制剂。研究发现该化合物可在纳摩尔范围内抑制人 CYP11B2,并在经呋塞米治疗的食蟹猴模型中显示出降低醛固酮的作用。尽管人CYP11B2与人CYP11B1具有高度同源性序列,但化合物在体外表现出比人CYP11B1高80倍以上的选择性。